Loading...
Loading...
OM| Name | Value |
|---|---|
| Revenues | 29.5M |
| Cost of Revenue | 18.7M |
| Gross Profit | 10.7M |
| Operating Expense | 32.6M |
| Operating I/L | -21.9M |
| Other Income/Expense | -3.8M |
| Interest Income | 2.0M |
| Pretax | -25.6M |
| Income Tax Expense | -0.0M |
| Net Income/Loss | -25.6M |
Outset Medical, Inc. develops the Tablo Hemodialysis System, a compact console that integrates water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The system is the primary source of revenue for the company, providing a comprehensive solution for hemodialysis. Outset Medical, Inc. focuses on the development and commercialization of its innovative hemodialysis system to generate profits.
